• Explore /
  • Poster
  • / Quantification of BCR-ABL by digital PCR in samples with high copy numbers and rates of molecular responses (as defined by EUTOS) compared to those detected with standard quantitative real-time PCR.

Quantification of BCR-ABL by digital PCR in samples with high copy numbers and rates of molecular responses (as defined by EUTOS) compared to those detected with standard quantitative real-time PCR.

Abstract Poster

Authors

null

Georg-Nikolaus Franke

Universitatsklinikum Leipzig AoR, Abt. Hamatologie und internistische Onkologie, Leipzig, Germany

Georg-Nikolaus Franke , Jacqueline Maier , Michael Cross , Kathrin Wildenberger , Francis J. Giles , Oliver Frank , Andreas Hochhaus , Christian Dietz , Martin C. Müller , Dietger Niederwieser , Thoralf Lange

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Chronic Leukemia—CML

Citation

J Clin Oncol 34, 2016 (suppl; abstr 7056)

DOI

10.1200/JCO.2016.34.15_suppl.7056

Abstract #

7056

Poster Bd #

48

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

4-year results of the ponatinib phase II PACE trial in patients (pts) with heavily pretreated leukemia.

4-year results of the ponatinib phase II PACE trial in patients (pts) with heavily pretreated leukemia.

First Author: Jorge E. Cortes

First Author: Francois-Xaxier Mahon

First Author: Benjamin J. Solomon

First Author: Nelson Spector